October 26, 2017 / 1:12 PM / 24 days ago

BRIEF-India's Biocon Sept-qtr consol profit more than halves

Oct 26 (Reuters) - Biocon Ltd

* Sept quarter consol profit 688 million rupees versus 1.47 billion rupees last year

* Consensus forecast for Sept quarter consol profit was 1.14 billion rupees

* Sept quarter consol revenue from operations 9.69 billion rupees versus 9.54 billion rupees last year

* Approved transfer of biosimilars business by way of slump sale as a going concern to Biocon Biologics India Ltd, a step down unit of co‍​

* Says “expect headwinds to ease by the end of this fiscal”‍​

* "Malaysia facility costs and pricing pressures in our APIs business continue to weigh on our P&L" Source text: (bit.ly/2lhfHH8) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below